Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Vilin Bio Med Ltd (VILINBIO)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: VILINBIO Pharmaceuticals & Drugs | Small Cap | Vilin Bio Med Share Price
BSE Share Price
Not Listed
Not Listed
Vilin Bio Med Ltd (VILINBIO)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: VILINBIO Pharmaceuticals & Drugs | Small Cap | Vilin Bio Med Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹79 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.9
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
185.35%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
56.65%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹15.3 Cr.
Face Value
₹10
All Time Low / High
₹0.00 / 0.00
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Vilin Bio Med Ltd a good quality company?
Vilin Bio Med Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Vilin Bio Med Ltd performance compare with that of its Peers?
Revenue growth of Vilin Bio Med Ltd vs industry peers?
Vilin Bio Med Ltd revenue CAGR is %, compared to the industry median CAGR of 0.00%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Vilin Bio Med Ltd?
Promoters hold 56.65% of the Vilin Bio Med Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Vilin Bio Med Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of 31.02% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vilin Bio Med Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 5.1% | 4.9% | 4.3% | 17.2% | 4.5% | 4.2% | 10.7% | - |
| Value Creation Index ⓘ | -0.6 | -0.7 | -0.7 | 0.2 | -0.7 | -0.7 | -0.2 | - |
Growth Parameters ⓘ |
||||||||
| Sales ⓘ | 16.8 | 11.7 | 11.2 | 12.3 | 15.8 | 14.8 | 42.3 | 42 |
| Sales YoY Gr. | - | -30.3% | -4.4% | 9.8% | 28.4% | -6.3% | 185.4% | - |
| Adj EPS ⓘ | 0.4 | 0.3 | 0 | 1.3 | 0.1 | 0.2 | 1.3 | 1.3 |
| YoY Gr. | - | -16.7% | -86.7% | 3025% | -90.4% | 33.3% | 687.5% | - |
| BVPS (₹) ⓘ | 8.8 | 8.9 | 9 | 10.7 | 16.4 | 16.5 | 18.6 | 18.6 |
| Adj Net Profit ⓘ | 0.3 | 0.3 | 0 | 1.3 | 0.2 | 0.2 | 1.9 | 2 |
| Cash Flow from Ops. ⓘ | -1.5 | -1 | 0.2 | -1.7 | -7.4 | 0.2 | 0.7 | - |
| Debt/CF from Ops. ⓘ | -3.1 | -5.5 | 25.4 | -3 | -0.9 | 12 | 0.3 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 29.2% | 50.9% | 185.4% | ||||
| Adj EPS ⓘ | NA | 33.2% | 0.3% | 687.5% | ||||
| BVPSⓘ | NA | 15.8% | 20.1% | 12.5% | ||||
| Share Price | - | - | 32.8% | 92.9% | ||||
Key Financial Parameters ⓘ
| Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 4.1 | 3.4 | 0.5 | 13.8 | 1 | 1 | 7.5 | 6.8 |
| Op. Profit Mgn % ⓘ | 6.5 | 8.7 | 6.8 | 20.9 | 5.2 | 5.3 | 7.6 | NAN |
| Net Profit Mgn % ⓘ | 1.8 | 2.1 | 0.3 | 10.1 | 1 | 1.5 | 4.6 | 4.6 |
| Debt to Equity ⓘ | 0.6 | 0.8 | 0.7 | 0.5 | 0.3 | 0.1 | 0 | - |
| Working Cap Days ⓘ | 0 | 371 | 388 | 415 | 475 | 614 | 240 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 252 | 296 | 204 | 150 | 240 | 133 | 0 |
Valuation of Vilin Bio Med - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Vilin Bio Med Ltd FAQs
The current trading price of Vilin Bio Med on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Vilin Bio Med stood at ₹78.54 Cr
The latest P/E ratio of Vilin Bio Med as of 31-Dec-1969 is 40.71.
The latest P/B ratio of Vilin Bio Med as of 31-Dec-1969 is 2.77.
The 52-week high of Vilin Bio Med is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vilin Bio Med is ₹42.26 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vilin Bio Med Ltd is a below average quality company.
The key valuation ratios of Vilin Bio Med Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vilin Bio Med Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Vilin Bio Med Ltd
The company was originally incorporated as a public limited company under the Companies Act, 1956 pursuant to a certificate of incorporation issued by the Registrar of Companies, Andhra Pradesh, Hyderabad dated June 29, 2005 with the name ‘Vilin Bio Med Limited’. It received a certificate of commencement of business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad.
The company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand. In order to maintain its competitiveness and to further the cause of Healthcare, the company has laid a R&D Foundation and state of the art Manufacturing Facility in Roorkee. Its Sales Strategy is to sell its products in bulk to Pharmaceuticals Manufacturers, Marketers and Traders, who in turn provide the channel for sales to customers. Its products are primarily used by other pharmaceutical companies and traders, who ultimately will market it to the distributors and retail customers. It do not sell its products under any brand name.
Vilin Bio Med is engaged in the manufacturing of pharmaceuticals formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non Beta Lactam tablets and Capsules & Nutritional Food supplements. Its Promoters, Mr. Sadhanala Venkata Rao, Mr. Viswa Prasad Sadhanala, Mr. D. Srinivasa Reddy, and Mr. Anuj Bajpai are actively involved in the day-to-day business. Its Promoters are the guiding force behind the Strategic Decisions of the company. Their Industry Knowledge and understanding of the current market situation enables it to improve its geographic horizon and market presence.
Business area of the company
The company is engaged in the manufacturing of pharmaceuticals formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non Beta Lactam tablets and Capsules & Nutritional Food supplements.
Products of the company
- Cardiovascular drugs
- Musculo-Skeletal drugs
- Antibiotics drugs
- Central nervous system drugs
- Alimentary sytem drugs
- Genito-Urinary tract drugs
- Respiratory system & anti-allergics drugs
- Anti- diabetic drugs
- Multi-vitamins, minerals & amino acids supplements
- Miscellaneous drugs
- Liquid orals
History and milestone
- 2005: Company Incorporation.
- 2006: First Commercial production.
- 2007: Expansion of Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections.
- 2010: It has received more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio.
- 2012: 120 different styles of Packing’s including physician sample packs to meet all types packing requirements in the market.
- 2014: Added the Sachet section in Non-Beta Lactum facility.
- 2015: More than 20 different Punches in different dimensions of the tablet including size and volume to meet all the customer requirements.
- 2021: New Promoters are inducted to strengthen the Management of the Company
- 2022: Company appointed Professionals on the Board to strengthen the Board and Corporate Governance.
You have 42 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
